Following the White House’s recent announcement of price reductions and expanded coverage for GLP-1 medications like Wegovy and Zepbound, many patients searching for obesity treatments are about to ...

Obesity is a growing global health crisis, affecting millions of people and increasing the risk of chronic diseases like diabetes, heart disease, and stroke. However, the good news is that obesity is ...

Does informing people about their genetic risk of obesity help them change their habits and lose excess weight? A study ...

Editorial: Obesity reflects prices, advertising and access, not simply weak willpower. Ministers must now act ...

SAN ANTONIO — The upcoming Obesity Week meeting will feature new clinical trial data for glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs, along with deep dives into clinical, social, and ...

Does informing people about their genetic risk of obesity help them change their habits and lose excess weight? A study, published in the journal Obesity Reviews by scientists including researchers ...

Nineteen states and two territories have at least 35% of residents with adult obesity – more than doubling the number of states with a high obesity prevalence since 2018 – according to data from the ...

Childhood obesity is a serious health problem that has adverse and long-lasting consequences for individuals, families, and communities. The magnitude of the problem has increased dramatically over ...

A review suggests that although obesity medications, such as GLP-1 drugs, can result in substantial weight loss, many obesity ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...